Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Resonate BlendsKOAN Pretax Margin % is -399.59% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 961 Drug Manufacturers companies, Resonate Blends ranks worse than 93.44% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Resonate Blends Pretax Margin % Related Terms
Resonate Blends Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Resonate Blends's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KOAN vs PTPI, KAYS, OWPC: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonate Blends Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Resonate Blends's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonate Blends (KOAN) has a Pretax Margin % of -399.59% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Resonate Blends and its competitors. According to the industry distribution chart, Resonate Blends ranks #898 out of 961 companies in the Drug Manufacturers industry, placing it in the top 93.4%.
Is Resonate Blends' Pretax Margin % too high?
Resonate Blends' current Pretax Margin % is -399.59%. Based on the distribution chart, Resonate Blends ranks #898 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Resonate Blends' Pretax Margin % compare to PTPI and KAYS?
According to the Drug Manufacturers industry distribution chart, Resonate Blends ranks #898 out of 961 companies for Pretax Margin %. This places Resonate Blends in the lower half of its industry. The industry median Pretax Margin % is 7.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.06, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Resonate Blends and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonate Blends's current Pretax Margin % is -399.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonate Blends stock overvalued right now?
Resonate Blends (KOAN) has a current Pretax Margin % of -399.59%. The current Pretax Margin % is -399.59%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Resonate Blends (KOAN), the current Pretax Margin % is -399.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonate Blends Inc is engaged in the discovery, development, and marketing of nutritionally designed regenerative medicine and wellness products. The company focuses on natural stem cell mobilizing agents, diet aids, and bioactive formulations intended to enhance human performance and support health and wellness for consumer and professional markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KOAN has been successfully added to your 
